Belgium· BE-AMP-SAM310073-00

Isentress 400 mg

A raltegravir product containing raltegravir potassium, registered in Belgium by Merck Sharp & Dohme. The same ATC class is registered in 13 of our 19 countries.

ATC J05AJ01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedIsentress 400 mgATCJ05AJ01REGISTER NO.BE-AMP-SAM310073-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Raltegravir is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AJ01 (raltegravir), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose

Raltegravir · ATC J05AJ01

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of raltegravir costs, country by country.

Normalised to the WHO defined daily dose (0.8 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Raltegravir · price per daily dose (0.8 g)

USD · FX 28 Sept 2026

  • CH Switzerland$18.61
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Raltegravir Potassium
Manufacturer
Merck Sharp & Dohme
Country
Belgium (BE)
ATC code
J05AJ01
ATC class
Raltegravir
Defined daily dose
0.8 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    2485498
    EUR 500.29
  • be_apb
    0789974

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

55 interactions on record for raltegravir.

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Raltegravir · interactions on record

55 records

  • 15 severe
  • 22 moderate
  • 18 minor

Most severe, free to view

  • Magnesium carbonateA02AA01severe
  • Magnesium hydroxideA02AA04severe
  • Kombinationen von AluminiumsalzenA02AB10severe
  • Calcium carbonateA02AC01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Raltegravir in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All raltegravir products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Bulgaria · Raltegravir Viatris, Ралтегравир Зентива
  • Cyprus · Raltegravir Viatris
  • Germany · Raltegravir Axiromed, Raltegravir Beta
  • Denmark · Raltegravir Viatris, Raltegravir Zentiva
  • Estonia · Raltegravir Viatris, Raltegravir Zentiva
  • Spain · Raltegravir Dr. Reddys, Raltegravir Zentiva
  • Finland · Raltegravir Viatris, Raltegravir Zentiva
  • France · Raltegravir Biogaran, Raltégravir Biogaran
  • United Kingdom (Northern Ireland) · Raltegravir Amarox, Raltegravir Dr. Reddy's Laboratories (Uk)
  • Greece · Ralpecin, Raltegravir Viatris
  • Croatia · Raltegravir Viatris
  • Iceland · Isentress, Raltegravir Zentiva
  • Italy · Raltegravir Dr. Reddy’s, Raltegravir Mylan
  • Liechtenstein · Isentress
  • Lithuania · Raltegravir Zentiva
  • Latvia · Raltegravir Viatris, Raltegravir Zentiva
  • Malta · Raltegravir Viatris
  • Netherlands · Raltegravir Rockmed Pharma, Raltegravir Viatris
  • Norway · Isentress, Raltegravir Viatris
  • Poland · Raltegravir Viatris
  • Portugal · Raltegravir Mylan, Raltegravir Zentiva
  • Romania · Raltegravir Viatris, Raltegravir Zentiva
  • Sweden · Raltegravir Zentiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a17e6410-78f8-4f9e-89d7-11a44818fec3
GET /v1/drugs/a17e6410-78f8-4f9e-89d7-11a44818fec3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Isentress 400 mg",
  "name_fr": "Isentress 400 mg",
  "name_nl": "Isentress 400 mg",
  "amp_code": "SAM310073-00",
  "strengths": [
    "400.0000",
    "26.0600"
  ],
  "pack_count": 2,
  "substances": [
    "Raltegravir Potassium",
    "Raltegravir",
    "Lactose Monohydrate",
    "Sodium Stearyl Fumarate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Raltegravir",
  "authorisation_numbers": [
    "EU/1/07/436/001",
    "EU/1/07/436/002"
  ]
}

See everything about raltegravir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.